Sound Income Strategies’s Zevra Therapeutics ZVRA Stock Holding History

Sound Income Strategies’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-625	Closed	-$2K	–	893
2020 Q1	$2K	Hold	625	–	–	﹤0.01%	619
2019 Q4	$4K	Hold	625	–	–	﹤0.01%	502
2019 Q3	$7K	Hold	625	–	–	﹤0.01%	388
2019 Q2	$18K	Hold	625	–	–	0.01%	246
2019 Q1	$17K	Hold	625	–	–	0.01%	253
2018 Q4	$18K	Hold	625	–	–	0.01%	253
2018 Q3	$48K	Buy	+625	New	+$48.8K	0.02%	135

Other funds holding ZVRA

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

BBVA

Banco Bilbao Vizcaya Argentaria Madrid, Spain $14.3B AUM 26.23% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ISB

Iowa State Bank Urbandale, Iowa $598M AUM 26.27% 1-Year Est. Return

Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

Sound Income Strategies's ZVRA Position: Q2 2020 in Review

Sound Income Strategies sold out of Zevra Therapeutics (ZVRA) in Q2 2020, closing a stake of 625 shares — an estimated $2K sold.

Sound Income Strategies first reported a position in ZVRA in Q3 2018 and held it in 7 quarters. The position peaked at $48K in Q3 2018. 6 funds tracked by Wall St. Rank hold ZVRA as of Q2 2020.

Sound Income Strategies reported no remaining Zevra Therapeutics position as of Q2 2020 after selling out during the quarter.
Sound Income Strategies sold 625 Zevra Therapeutics shares in Q2 2020, an estimated $2K.
Sound Income Strategies first reported a position in Zevra Therapeutics in Q3 2018 and held it in 7 quarters.
Sound Income Strategies's Zevra Therapeutics position peaked at $48K in Q3 2018.
6 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2020.

Based on Sound Income Strategies's 13F filing for Q2 2020, filed 13 Jul 2020.